Optimizing Therapeutic Drug Monitoring of Tumor Necrosis Factor-α Antagonists in Patients With Inflammatory Bowel Diseases Reply

被引：0
|
作者：
Ben-Horin, Shomron [1 ,2 ]
Ungar, Bella [1 ,2 ]
机构：
[1] Tel Aviv Univ, Sheba Med Ctr Tel Hashomer, Dept Gastroenterol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2016年 / 14卷 / 10期
关键词：
D O I：
10.1016/j.cgh.2016.06.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1509 / 1510
页数：3
相关论文
共 50 条
  • [41] Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey
    Oussalah, A.
    Roblin, X.
    Laharie, D.
    Filippi, J.
    Flamant, M.
    Faure, P.
    Phelip, J. -M.
    Bigard, M. -A.
    Peyrin-Biroulet, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (08) : 854 - 863
  • [42] Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases
    Bank, Steffen
    Andersen, Paal Skytt
    Burisch, Johan
    Pedersen, Natalia
    Roug, Stine
    Galsgaard, Julie
    Turino, Stine Ydegaard
    Brodersen, Jacob Broder
    Rashid, Shaista
    Avlund, Sara
    Olesen, Thomas Bastholm
    Green, Anders
    Hoffmann, Hans Jurgen
    Thomsen, Marianne Kragh
    Thomsen, Vibeke Ostergaard
    Nexo, Bjorn Andersen
    Vogel, Ulla
    Andersen, Vibeke
    DANISH MEDICAL JOURNAL, 2015, 62 (03):
  • [43] The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease
    Joosse, Maria E.
    Samsom, Janneke N.
    van der Woude, C. Janneke
    Escher, Johanna C.
    van Gelder, Teun
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (09) : 2214 - 2221
  • [44] A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists
    Townsend, Cassandra M.
    Khanna, Reena
    Wilson, Aze Suzanne
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4436 - 4440
  • [45] A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists
    Cassandra M. Townsend
    Reena Khanna
    Aze Suzanne Wilson
    Digestive Diseases and Sciences, 2021, 66 : 4436 - 4440
  • [46] Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease (vol 311, pg 2406, 2014)
    Andersen, Nynne Nyboe
    Pasternak, Bjoern
    Basit, Saima
    Andersson, Mikael
    Svanstroem, Henrik
    Caspersen, Sarah
    Munkholm, Pia
    Hviid, Anders
    Jess, Tine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (23): : A2406 - A2406
  • [47] Infections associated with tumor necrosis factor-α antagonists
    Crum, NF
    Lederman, ER
    Wallace, MR
    MEDICINE, 2005, 84 (05) : 291 - 302
  • [48] Infectious complications of tumor necrosis factor-α antagonists
    Bakleh, M
    Tleyjeh, I
    Matteson, EL
    Osmon, DR
    Berbari, EF
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2005, 44 (06) : 443 - 448
  • [49] Infections associated with tumor necrosis factor-α antagonists
    Rychly, DJ
    DiPiro, JT
    PHARMACOTHERAPY, 2005, 25 (09): : 1181 - 1192
  • [50] Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases
    Singh, Siddharth
    Iversen, Aske T.
    Allin, Kristine H.
    Jess, Tine
    JAMA NETWORK OPEN, 2022, 5 (09) : E2234200
12345